Allylamine → N-(5-{5-[(allylamino)sulfonyl]-2-bromo-3-thienyl}-4-methyl-1,3-thiazol-2-yl)acetamide
反応式
[C:1]([NH:4][C:5]1[S:6][C:7]([C:11]2[CH:12]=[C:13]([S:17](Cl)(=[O:19])=[O:18])[S:14][C:15]=2[Br:16])=[C:8]([CH3:10])[N:9]=1)(=[O:3])[CH3:2].[CH2:21]([NH2:24])[CH:22]=[CH2:23].CCN(C(C)C)C(C)C>C(Cl)Cl>[CH2:21]([NH:24][S:17]([C:13]1[S:14][C:15]([Br:16])=[C:11]([C:7]2[S:6][C:5]([NH:4][C:1](=[O:3])[CH3:2])=[N:9][C:8]=2[CH3:10])[CH:12]=1)(=[O:19])=[O:18])[CH:22]=[CH2:23]参加物
5
実験手順
4-[2-(Acetylamino)-4-methyl-1,3-thiazol-5-yl]-5-bromothiophene-2-sulfonylchloride, prepared as in Step III of Example 23 (100 mg; 0.229 mmol; 1 eq) is dissolved in DCM (10 ml). Allyl amine (0.15 ml; 1.14 mmol; 5 eq) and DIEA (0.17 ml; 0.70 mmol; 3 eq) are added under a nitrogen atmosphere. After 2 hours reaction, solvents are evaporated. The crude product is dissolved in DCM and washed with NH4Cl saturated solution, water and dried over MgSO4. After evaporation of the solvents, crude material is purified by reverse preparative HPLC, affording N-(5-{5-[(allylamino)sulfonyl]-2-bromo-3-thienyl}-4-methyl-1,3-thiazol-2-yl)acetamide as a white solid (35 mg; 35%).
後処理
- customAfter 2 hours reaction, solvents
- customare evaporated
- dissolutionThe crude product is dissolved in DCM
- washwashed with NH4Cl saturated solution, water
- dry with materialdried over MgSO4
- customAfter evaporation of the solvents, crude material
- customis purified by reverse preparative HPLC
出典と根拠
- ORDレコード
- ord-edacf76aadcb45e9bc5534d5af11117f
- 出典データセット
- uspto-grants-2011_02
- 特許番号
- US07879888B2
反応ノート
読み込み中…